The Cancer Genome Atlas Pan-Cancer analysis project showed and declared that the level of IL-33 expression is altered in only 3% of ~580 tumors and that the most common genetic alteration is the deletion of the IL-33 gene (64). This evidence concerns the gene IL33 and cancer.